Project Grant HT94252510328
Award Date
5/15/25
Completion Date
5/14/28
Dollars Obligated
$877K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
This $598,130 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) was provided to Cedars-Sinai Medical Center in West Hollywood, CA. The funding supports a 2-year research project from February 2025 to February 2027 focused on investigating the "Determinants of Lung Cancer-Associated Cachexia". As a prominent academic medical center, Cedars-Sinai has extensive experience executing federal research...
This federal Project Grant award of $2,685,519.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) grant program. The grant supports research conducted by Cedars-Sinai Medical Center in West Hollywood, California to investigate "Defining Human Correlates of Super-Evasive Disseminated Tumor Cells, Their Pathological Relevance and How to Eradicate Them." The award has a performance period from July 1, 2025 to June 30, 2029. As a...
This $4,089,970 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Cedars-Sinai Medical Center to investigate spatial reprogramming of tumor immune microenvironments through preoperative radiotherapy and immune checkpoint inhibition in HER2 negative breast cancer. The award will fund basic, translational, and clinical research over 4 years from September 2023 to August 2027 to develop new treatments,...
This $1,251,673.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center on August 1, 2023. The grant will fund research aimed at re-engineering the intratumoral myeloid-macrophage compartment to enhance the response to radiation and immunotherapy in triple-negative breast cancer. The three-year project will be performed at Cedars-Sinai's facilities in West Hollywood, CA. As a leading...
This Project Grant award of $1,252,479.00 from the Defense Health Agency supports Cedars-Sinai Medical Center's biomedical research to re-engineer the intratumoral myeloid-macrophage compartment and enhance the response to radiation and immunotherapy in triple-negative breast cancer. The award falls under the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for Service Members and the public through innovative and impactful research....
The Defense Health Agency awarded Cedars-Sinai Medical Center a $667,963 Project Grant to "INVESTIGATE EXTRACELLULAR MATRIX PROTEINS LOCAL AND SYSTEMIC ROLE IN PROMOTING SOFT TISSUE SARCOMA" over the period of 09/01/2023 to 08/30/2025. This award was made under the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. As a...
The U.S. Department of Defense awarded a $1,000,000.00 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420) to evaluate short- and long-term systemic anti-tumor immunity following combined radiation and immunotherapy in triple-negative breast cancer. This 4-year research project, which commenced on Sep 15, 2023 and is scheduled for completion by Sep 14, 2027, aims to investigate medical solutions for transforming healthcare for...
The Department of the Army Medical Command awarded Cedars-Sinai Medical Center a $1,252,233 Project Grant on September 30, 2022 to support research titled "NOVEL LINEAGE PLASTICITY INHIBITORS IN PROSTATE CANCER." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues. Under this award, Cedars-Sinai...
The U.S. Department of Defense (DoD) has awarded a $3,056,435 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420) to conduct a 4-year evaluation of short- and long-term systemic anti-tumor immunity following combined radiation and immunotherapy treatments in triple-negative breast cancer. The award, effective September 15, 2023, will support the medical center's biomedical research efforts to investigate novel therapeutic...
The Department of Defense's Defense Health Agency awarded a $1,164,294 Project Grant to Cedars-Sinai Medical Center on September 15, 2024 under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a 4-year project to correlate prostate-specific membrane antigen (PSMA) expression with molecular profiles in prostate cancer. Cedars-Sinai, a non-profit hospital and academic medical center, will conduct this biomedical research to advance understanding of...